Chlorogenic Acid Protects against Atherosclerosis in ApoE−/− Mice and Promotes Cholesterol Efflux from RAW264.7 Macrophages
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Chlorogenic acid (CGA) is one of the most abundant polyphenols in the human diet and is suggested to be a potential antiatherosclerotic agent due to its proposed hypolipidemic, anti-inflammatory and antioxidative properties. The aim of this study was to evaluate the effect of CGA on atherosclerosis development in ApoE(-/-) mice and its potential mechanism. ApoE(-/-) mice were fed a cholesterol-rich diet without (control) or with CGA (200 and 400 mg/kg) or atorvastatin (4 mg/kg) for 12 weeks. During the study plasma lipid and inflammatory parameters were determined. Treatment with CGA (400 mg/kg) reduced atherosclerotic lesion area and vascular dilatation in the aortic root, comparable to atorvastatin. CGA (400 mg/kg) also significantly decreased plasma levels of total cholesterol, triglycerides and low-density lipoprotein-cholesterol as well as inflammatory markers. Supplementation with CGA or CGA metabolites-containing serum suppressed oxidized low-density lipoprotein (oxLDL)-induced lipid accumulation and stimulated cholesterol efflux from RAW264.7 cells. CGA significantly increased the mRNA levels of PPARγ, LXRα, ABCA1 and ABCG1 as well as the transcriptional activity of PPARγ. Cholesterol efflux assay showed that three major metabolites, caffeic, ferulic and gallic acids, significantly stimulated cholesterol efflux from RAW264.7 cells. These results suggest that CGA potently reduces atherosclerosis development in ApoE(-/-) mice and promotes cholesterol efflux from RAW264.7 macrophages. Caffeic, ferulic and gallic acids may be the potential active compounds accounting for the in vivo effect of CGA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Immunity, atherosclerosis and cardiovascular disease
Frostegård, J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-117 · Cited by 1,040 · cited 1×
“Atherosclerosis is a major cause of mortality and morbidity and is the single most important cause of cardiovascular disease (CVD) [1,2].”
BackgroundJohnston, K. L., Clifford, M. N., & Morgan, L. M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.728 · Cited by 590 · cited 1×
“As the daily intake of CGA by coffee drinkers ranges from 500–1000 mg [37], the non-significant effect of CGA on atherosclerotic lesion formation may be due to the low dasage.”
BackgroundHDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis
Tall, A. R., Yvan-Charvet, L., Terasaka, N., Pagler, T., & Wang, N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.001 · Cited by 540
Chlorogenic Acid Compounds from Coffee Are Differentially Absorbed and Metabolized in Humans ,
Monteiro, M., Farah, A., Perrone, D., Trugo, L. C., & Donangelo, C. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.10.2196 · Cited by 324 · cited 1×
“It has been intensively reported that caffeic, quininic, ferulic, gallic and vanillic acids are main metabolites in plasma and urine after CGA administration [42–44].”
BackgroundAkt3 Deficiency in Macrophages Promotes Foam Cell Formation and Atherosclerosis in Mice
Ding, L., Biswas, S., Morton, R. E., Smith, J. D., Hay, N., Byzova, T. V., Febbraio, M., & Podrez, E. A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.020 · Cited by 83 · cited 1×
“As atherosclerosis is considered as a multifactorial inflammatory disease and inflammation, oxidative stress, and macrophage foam cell formation are crucial processes in the development of atherosclerotic plaques [6], optimal therapeutic treatment of atherosclerosis should therefore encompass different approaches.”
Background
Research works printed but not linked: 37
- G Sirimarco, 2013, Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis, Stroke, 44, 373, 10.1161/STROKEAHA.112.673129 · DOI
- DC Goff Jr, 2006, Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium, Circulation, 113, 647, 10.1161/CIRCULATIONAHA.105.552737 · DOI · Paper page
- 2014, Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Eur Heart J, 35, 353, 10.1093/eurheartj/eht407 · DOI
- M Wang, 2013, Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus, Atherosclerosis, 229, 62, 10.1016/j.atherosclerosis.2013.01.017 · DOI
- TS Lee, 2010, Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages, J Cell Biochem, 111, 104, 10.1002/jcb.22667 · DOI · Paper page
- SM Lee, 2013, Quercetin up-regulates expressions of peroxisome proliferator-activated receptor gamma, liver X receptor alpha, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line, Nutr Res, 33, 136, 10.1016/j.nutres.2012.11.010 · DOI
- MA Kennedy, 2005, ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation, Cell Metab, 1, 121, 10.1016/j.cmet.2005.01.002 · DOI · Paper page
- ZH Wu, 2009, Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes, Pharmacology, 84, 282, 10.1159/000242999 · DOI
- R Upadhyay, 2013, An outlook on chlorogenic acids-occurrence, chemistry, technology, and biological activities, Crit Rev Food Sci Nutr, 53, 968, 10.1080/10408398.2011.576319 · DOI · Paper page
- KW Ong, 2012, Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes, PLoS One, 7, e32718, 10.1371/journal.pone.0032718 · DOI · Paper page
- A Suzuki, 2006, Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats, J Hypertens, 24, 1065, 10.1097/01.hjh.0000226196.67052.c0 · DOI · Paper page
- YJ Liu, 2013, Chlorogenic acid induced apoptosis and inhibition of proliferation in human acute promyelocytic leukemia HL60 cells, Mol Med Rep, 8, 1106, 10.3892/mmr.2013.1652 · DOI · Paper page
- CW Wan, 2013, Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-alpha in hypercholesterolemic rats induced with a high-cholesterol diet, Phytother Res, 27, 545, 10.1002/ptr.4751 · DOI · Paper page
- KW Ong, 2013, Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation, Biochem Pharmacol, 85, 1341, 10.1016/j.bcp.2013.02.008 · DOI · Paper page
- JG Xu, 2012, Antioxidant and DNA-protective activities of chlorogenic acid isomers, J Agric Food Chem, 60, 11625, 10.1021/jf303771s · DOI · Paper page
- Y Sato, 2011, In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid, Int J Pharm, 403, 136, 10.1016/j.ijpharm.2010.09.035 · DOI · Paper page
- J Shan, 2009, Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappaB and JNK/AP-1 activation, Int Immunopharmacol, 9, 1042, 10.1016/j.intimp.2009.04.011 · DOI · Paper page
- MD dos Santos, 2006, Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid, Biol Pharm Bull, 29, 2236, 10.1248/bpb.29.2236 · DOI · Paper page
- WM Loke, 2010, Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction, Arterioscler Thromb Vasc Biol, 30, 749, 10.1161/ATVBAHA.109.199687 · DOI · Paper page
- W de Haan, 2008, Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin, Circulation, 117, 2515, 10.1161/CIRCULATIONAHA.107.761965 · DOI · Paper page
- P Guo, 2010, Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase, J Pharmacol Sci, 113, 395, 10.1254/jphs.10041FP · DOI
- X Zhang, 2013, Anti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet, PLoS One, 8, e61922, 10.1371/journal.pone.0061922 · DOI
- HW Jeong, 2011, A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma, Diabetes, 60, 496, 10.2337/db09-1145 · DOI
- C Wu, 2012, HRS1 acts as a negative regulator of abscisic acid signaling to promote timely germination of Arabidopsis seeds, PLoS One, 7, e35764, 10.1371/journal.pone.0035764 · DOI
- H Shi, 2013, Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway, Toxicology, 303, 107, 10.1016/j.tox.2012.10.025 · DOI · Paper page
- L Gu, 2013, Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress, PLoS One, 8, e65477, 10.1371/journal.pone.0065477 · DOI
- J Zhang, 2011, Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol, Assay Drug Dev Technol, 9, 136, 10.1089/adt.2010.0288 · DOI · Paper page
- JM Choi, 2012, The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases, Mol Cells, 33, 217, 10.1007/s10059-012-2297-y · DOI · Paper page
- T Erk, 2012, Dose-dependent absorption of chlorogenic acids in the small intestine assessed by coffee consumption in ileostomists, Mol Nutr Food Res, 56, 1488, 10.1002/mnfr.201200222 · DOI · Paper page
- K Azuma, 2000, Absorption of chlorogenic acid and caffeic acid in rats after oral administration, J Agric Food Chem, 48, 5496, 10.1021/jf000483q · DOI · Paper page
- JF Berbée, 2013, Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice, J Nutr Biochem, 24, 1423, 10.1016/j.jnutbio.2012.11.009 · DOI
- SK Jain, 2009, Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats, Antioxid Redox Signal, 11, 241, 10.1089/ars.2008.2140 · DOI · Paper page
- H Shi, 2013, Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells, Inflamm Res, 62, 581, 10.1007/s00011-013-0610-7 · DOI
- R Ohashi, 2005, Reverse cholesterol transport and cholesterol efflux in atherosclerosis, QJM, 98, 845, 10.1093/qjmed/hci136 · DOI · Paper page
- R Ohnishi, 2006, Effects of chlorogenic acid and its metabolites on spontaneous locomotor activity in mice, Biosci Biotechnol Biochem, 70, 2560, 10.1271/bbb.60243 · DOI · Paper page
- H Uto-Kondo, 2010, Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages, Circ Res, 106, 779, 10.1161/CIRCRESAHA.109.206615 · DOI
- SH Park, 2011, Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages, J Nutr, 141, 1931, 10.3945/jn.111.144816 · DOI
Cited by
Nguyen, V., Taine, E. G., Meng, D., Cui, T., & Tan, W. (2024) · Nutrients · doi:10.3390/nu16070924 · Cited by 378
Chlorogenic Acid and Mental Diseases: From Chemistry to Medicine
Nabavi, S. F., Tejada, S., Setzer, W. N., Gortzi, O., Sureda, A., Braidy, N., Daglia, M., Manayi, A., & Nabavi, S. M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160325120625 · Cited by 152
Ren, K., Li, H., Zhou, H.-F., Liang, Y., Tong, M., Chen, L., Zheng, X.-L., & Zhao, G.-J. (2019) · Aging · doi:10.18632/aging.102498 · Cited by 83
Yuan, Q., Liu, C., Zhang, Z., Chen, F., Xiao, Q., Zhang, L., Pan, X., He, F., & Xiao, M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1613048 · Cited by 27
Gao, L., Zhang, T., Zhang, X., Ding, W., Yang, J., Luo, Y., Wang, J., Yuan, X., & Zhao, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1746172 · Cited by 4
Self-citation
Metadata
- Authors
- Wu, C., Luan, H., Zhang, X., Wang, S., Zhang, X., Sun, X., & Guo, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-09-04
- Volume
- 9
- Issue
- 9
- Pages
- e95452
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1996974531
- Cited by
- 106
- References
- 8
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chlorogenic Acid Protects against Atherosclerosis in ApoE−/− Mice and Promotes Cholesterol Efflux from RAW264.7 Macrophages. https://app.cochat.ai/papers/10.1371/journal.pone.0095452
- The paper
- Wu, C., Luan, H., Zhang, X., Wang, S., Zhang, X., Sun, X., & Guo, P. (2014). Chlorogenic Acid Protects against Atherosclerosis in ApoE−/− Mice and Promotes Cholesterol Efflux from RAW264.7 Macrophages. PLoS ONE. https://doi.org/10.1371/journal.pone.0095452
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.